BOSTON — In emergency department stroke consultations, the National Institute of Health Stroke Scale (NIHSS) alone does not appear to be a reliable guide for ordering diagnostic […]

In patients with radiologically isolated syndrome (RIS) predictive of multiple sclerosis (MS), teriflunomide reduced the risk of a demyelinating event by more than 60% over a […]

Untreated hearing loss increases dementia risk in middle-aged and older adults, new research confirms. A large observational study from the United Kingdom showed a 42% increased […]

LOS ANGELES — Though neurosurgeons remain the most highly paid physicians in the United States, a new study finds that the Medicare reimbursement rates for the […]

BOSTON – A novel levodopa/carbidopa delivery system fitted to a retainer worn in the mouth appears to achieve the advantages of continuous drug delivery without the […]

The investigational anti-amyloid drug donanemab (Eli Lilly) significantly slowed cognitive and functional decline in a phase 3 study of adults with early symptomatic Alzheimer’s disease (AD), […]

A large proportion of US adults who are prescribed Schedule II stimulants are simultaneously receiving other CNS agents including benzodiazepines, opioids, and antidepressants — a potentially […]

There has been an increase in the incidence and prevalence of myasthenia gravis (MG) in the United States, an analysis of new claims data shows. Investigators […]